메뉴 건너뛰기




Volumn 11, Issue 6, 2014, Pages 267-278

TCR-MHC/peptide interaction: Prospects for new anti-tumoral agents

Author keywords

Antibody mhc fusion proteins; Chimeric antigen receptors; Immunological synapse; Review; T cell receptor; T cell receptorbased fusion proteins

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; CHIMERIC ANTIGEN RECEPTOR; HYBRID PROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; SUPERANTIGEN; SUPERANTIGEN T LYMPHOCYTE FUSION PROTEIN; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR INTERLEUKIN 2 FUSION PROTEIN; T LYMPHOCYTE RECEPTOR LIKE ANTIBODY; UNCLASSIFIED DRUG; HISTOCOMPATIBILITY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; PROTEIN BINDING;

EID: 84912085635     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (7)

References (129)
  • 1
    • 0036229026 scopus 로고    scopus 로고
    • Structural basis of T cell recognition of peptides bound to MHC molecules
    • Wang JH and Reinherz EL: Structural basis of T cell recognition of peptides bound to MHC molecules. Mol Immunol 38:1039-1049, 2002.
    • (2002) Mol Immunol , vol.38 , pp. 1039-1049
    • Wang, J.H.1    Reinherz, E.L.2
  • 2
    • 20544463394 scopus 로고    scopus 로고
    • Antigen processing is predictable: From genes to T cell epitopes
    • Stevanovic S: Antigen processing is predictable: From genes to T cell epitopes. Transpl Immunol 14:171-174, 2005.
    • (2005) Transpl Immunol , vol.14 , pp. 171-174
    • Stevanovic, S.1
  • 3
    • 33845867675 scopus 로고    scopus 로고
    • Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells
    • Wahl A, Weidanz J and Hildebrand W: Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics 3:641-652, 2006.
    • (2006) Expert Rev Proteomics , vol.3 , pp. 641-652
    • Wahl, A.1    Weidanz, J.2    Hildebrand, W.3
  • 4
    • 12944325331 scopus 로고    scopus 로고
    • A listing of human tumor antigens recognized by T cells: March 2004 update
    • Novellino L, Castelli C and Parmiani G: A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 54:187-207, 2005.
    • (2005) Cancer Immunol Immunother , vol.54 , pp. 187-207
    • Novellino, L.1    Castelli, C.2    Parmiani, G.3
  • 5
    • 0035902080 scopus 로고    scopus 로고
    • Progress in human tumour immunology and immunotherapy
    • Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature 411:380-384, 2001.
    • (2001) Nature , vol.411 , pp. 380-384
    • Rosenberg, S.A.1
  • 6
    • 84255197842 scopus 로고    scopus 로고
    • Cancer immunotherapy comes of age
    • Mellman I, Coukos G and Dranoff G: Cancer immunotherapy comes of age. Nature 480:480-489, 2011.
    • (2011) Nature , vol.480 , pp. 480-489
    • Mellman, I.1    Coukos, G.2    Dranoff, G.3
  • 8
    • 0034669973 scopus 로고    scopus 로고
    • Generation of T cells specific for the wild-type sequence p53 (264-272) peptide in cancer patients: Implications for immunoselection of epitope loss variants
    • Hoffmann TK, Nakano K, Elder EM, Dworacki G, Finkelstein SD, Appella E, Whiteside TL and DeLeo AB: Generation of T cells specific for the wild-type sequence p53 (264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants. J Immunol 165:5938-5944, 2000.
    • (2000) J Immunol , vol.165 , pp. 5938-5944
    • Hoffmann, T.K.1    Nakano, K.2    Elder, E.M.3    Dworacki, G.4    Finkelstein, S.D.5    Appella, E.6    Whiteside, T.L.7    DeLeo, A.B.8
  • 16
    • 84855804372 scopus 로고    scopus 로고
    • Interleukin-15 biology and its therapeutic implications in cancer
    • Steel JC, Waldmann TA and Morris JC: Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci 33:35-41, 2012.
    • (2012) Trends Pharmacol Sci , vol.33 , pp. 35-41
    • Steel, J.C.1    Waldmann, T.A.2    Morris, J.C.3
  • 19
    • 0026077824 scopus 로고
    • Staphylococcal enterotoxin microbial superantigens
    • Johnson HM, Russell JK and Pontzer CH: Staphylococcal enterotoxin microbial superantigens. FASEB J 5:2706-2712, 1991.
    • (1991) FASEB J , vol.5 , pp. 2706-2712
    • Johnson, H.M.1    Russell, J.K.2    Pontzer, C.H.3
  • 21
    • 0029854470 scopus 로고    scopus 로고
    • Immune response during tumor therapy with antibody-superantigen fusion proteins
    • Rosendahl A, Hansson J, Sundstedt A, Kalland T and Dohlsten M: Immune response during tumor therapy with antibody-superantigen fusion proteins. Int J Cancer 68:109-113, 1996.
    • (1996) Int J Cancer , vol.68 , pp. 109-113
    • Rosendahl, A.1    Hansson, J.2    Sundstedt, A.3    Kalland, T.4    Dohlsten, M.5
  • 25
    • 0025060715 scopus 로고
    • Isolation and characterization of 5T4, a tumor-associated antigen
    • Hole N and Stern PL: Isolation and characterization of 5T4, a tumor-associated antigen. Int J Cancer 45:179-184, 1990.
    • (1990) Int J Cancer , vol.45 , pp. 179-184
    • Hole, N.1    Stern, P.L.2
  • 29
    • 0042971650 scopus 로고    scopus 로고
    • Molecular interactions mediating T cell antigen recognition
    • van der Merwe PA and Davis SJ: Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 21:659-684, 2003.
    • (2003) Annu Rev Immunol , vol.21 , pp. 659-684
    • Van Der Merwe, P.A.1    Davis, S.J.2
  • 32
    • 84886945598 scopus 로고    scopus 로고
    • ImmTACs: Novel bi-specific agents for targeted cancer therapy
    • Oates J and Jakobsen BK: ImmTACs: Novel bi-specific agents for targeted cancer therapy. Oncoimmunology 2: e22891, 2013.
    • (2013) Oncoimmunology , vol.2 , pp. e22891
    • Oates, J.1    Jakobsen, B.K.2
  • 33
    • 67449156132 scopus 로고    scopus 로고
    • Bispecific T cell engaging antibodies for cancer therapy
    • Baeuerle PA and Reinhardt C: Bispecific T cell engaging antibodies for cancer therapy. Cancer Res 69:4941-4944, 2009.
    • (2009) Cancer Res , vol.69 , pp. 4941-4944
    • Baeuerle, P.A.1    Reinhardt, C.2
  • 38
    • 12344322695 scopus 로고    scopus 로고
    • High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3
    • Chlewicki LK, Holler PD, Monti BC, Clutter MR and Kranz DM: High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol 346:223-239, 2005.
    • (2005) J Mol Biol , vol.346 , pp. 223-239
    • Chlewicki, L.K.1    Holler, P.D.2    Monti, B.C.3    Clutter, M.R.4    Kranz, D.M.5
  • 39
    • 71049153709 scopus 로고    scopus 로고
    • Cancer/testis (CT) antigens: Potential targets for immunotherapy
    • Caballero OL and Chen YT: Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100:2014-2021, 2009.
    • (2009) Cancer Sci , vol.100 , pp. 2014-2021
    • Caballero, O.L.1    Chen, Y.T.2
  • 40
    • 84862228799 scopus 로고    scopus 로고
    • Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma
    • Syed ON, Mandigo CE, Killory BD, Canoll P and Bruce JN: Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma. J Clin Neurosci 19:1016-1021, 2012.
    • (2012) J Clin Neurosci , vol.19 , pp. 1016-1021
    • Syed, O.N.1    Mandigo, C.E.2    Killory, B.D.3    Canoll, P.4    Bruce, J.N.5
  • 44
    • 0033924550 scopus 로고    scopus 로고
    • Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression
    • Tussey L, Speller S, Gallimore A and Vessey R: Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur J Immunol 30:1823-1829, 2000.
    • (2000) Eur J Immunol , vol.30 , pp. 1823-1829
    • Tussey, L.1    Speller, S.2    Gallimore, A.3    Vessey, R.4
  • 48
    • 0032520053 scopus 로고    scopus 로고
    • HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) downregulation in high-grade primary breast carcinoma lesions
    • Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ and Ferrone S: HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) downregulation in high-grade primary breast carcinoma lesions. Cancer Res 58:737-742, 1998.
    • (1998) Cancer Res , vol.58 , pp. 737-742
    • Vitale, M.1    Rezzani, R.2    Rodella, L.3    Zauli, G.4    Grigolato, P.5    Cadei, M.6    Hicklin, D.J.7    Ferrone, S.8
  • 49
    • 0034053497 scopus 로고    scopus 로고
    • Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
    • Ogg GS, Dunbar PR, Cerundolo V, McMichael AJ, Lemoine NR and Savage P: Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes. Br J Cancer 82:1058-1062, 2000.
    • (2000) Br J Cancer , vol.82 , pp. 1058-1062
    • Ogg, G.S.1    Dunbar, P.R.2    Cerundolo, V.3    McMichael, A.J.4    Lemoine, N.R.5    Savage, P.6
  • 50
    • 0033747396 scopus 로고    scopus 로고
    • Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes
    • Robert B, Guillaume P, Luescher I, Romero P and Mach JP: Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. Eur J Immunol 30:3165-3170, 2000.
    • (2000) Eur J Immunol , vol.30 , pp. 3165-3170
    • Robert, B.1    Guillaume, P.2    Luescher, I.3    Romero, P.4    Mach, J.P.5
  • 51
    • 0036533526 scopus 로고    scopus 로고
    • Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice
    • Savage P, Cowburn P, Clayton A, Man S, Lawson T, Ogg G, Lemoine N, McMichael A and Epenetos A: Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice. Int J Cancer 98:561-566, 2002.
    • (2002) Int J Cancer , vol.98 , pp. 561-566
    • Savage, P.1    Cowburn, P.2    Clayton, A.3    Man, S.4    Lawson, T.5    Ogg, G.6    Lemoine, N.7    McMichael, A.8    Epenetos, A.9
  • 52
    • 3142582516 scopus 로고    scopus 로고
    • Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments
    • Robert B, Guillaume P, Luescher I, Doucey MA, Cerottini JC, Romero P and Mach JP: Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments. Cancer Immun 1:2, 2001.
    • (2001) Cancer Immun , vol.1 , pp. 2
    • Robert, B.1    Guillaume, P.2    Luescher, I.3    Doucey, M.A.4    Cerottini, J.C.5    Romero, P.6    Mach, J.P.7
  • 53
    • 3042743864 scopus 로고    scopus 로고
    • In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts
    • Donda A, Cesson V, Mach JP, Corradin G, Primus FJ and Robert B: In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts. Cancer Immunity 3:11, 2003
    • (2003) Cancer Immunity , vol.3 , pp. 11
    • Donda, A.1    Cesson, V.2    Mach, J.P.3    Corradin, G.4    Primus, F.J.5    Robert, B.6
  • 54
    • 34249693089 scopus 로고    scopus 로고
    • Novel antibodies as anticancer agents
    • Zafir-Lavie I, Michaeli Y and Reiter Y: Novel antibodies as anticancer agents. Oncogene 26:3714-3733, 2007.
    • (2007) Oncogene , vol.26 , pp. 3714-3733
    • Zafir-Lavie, I.1    Michaeli, Y.2    Reiter, Y.3
  • 55
    • 0037105621 scopus 로고    scopus 로고
    • Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes
    • Lev A, Novak H, Segal D and Reiter Y: Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes. J Immunol 169:2988-2996, 2002.
    • (2002) J Immunol , vol.169 , pp. 2988-2996
    • Lev, A.1    Novak, H.2    Segal, D.3    Reiter, Y.4
  • 56
    • 22244440749 scopus 로고    scopus 로고
    • Antibodymediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes
    • Oved K, Lev A, Noy R, Segal D and Reiter Y: Antibodymediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes. Cancer Immunol Immunother 54:867-879, 2005.
    • (2005) Cancer Immunol Immunother , vol.54 , pp. 867-879
    • Oved, K.1    Lev, A.2    Noy, R.3    Segal, D.4    Reiter, Y.5
  • 57
    • 2942630604 scopus 로고    scopus 로고
    • Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo
    • Lev A, Noy R, Oved K, Novak H, Segal D, Walden P, Zehn D and Reiter Y: Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo. Proc Natl Acad Sci USA 101:9051-9056, 2004.
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 9051-9056
    • Lev, A.1    Noy, R.2    Oved, K.3    Novak, H.4    Segal, D.5    Walden, P.6    Zehn, D.7    Reiter, Y.8
  • 59
    • 1242329830 scopus 로고    scopus 로고
    • Epidermal growth factor receptor: A promising target in solid tumors
    • Laskin JJ and Sandler AB: Epidermal growth factor receptor: a promising target in solid tumors. Cancer Treat Rev 30:1-17, 2004.
    • (2004) Cancer Treat Rev , vol.30 , pp. 1-17
    • Laskin, J.J.1    Sandler, A.B.2
  • 60
    • 3042663513 scopus 로고    scopus 로고
    • Cetuximab in advanced non-small cell lung cancer
    • Govindan R. Cetuximab in advanced non-small cell lung cancer. Clin Cancer Res 10:4241s-4244s, 2004.
    • (2004) Clin Cancer Res , vol.10 , pp. 4241s-4244s
    • Govindan, R.1
  • 61
    • 33845625695 scopus 로고    scopus 로고
    • Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo
    • Novak H, Noy R, Oved K, Segal D, Wels WS and Reiter Y: Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo. Int J Cancer 120:329-336, 2007.
    • (2007) Int J Cancer , vol.120 , pp. 329-336
    • Novak, H.1    Noy, R.2    Oved, K.3    Segal, D.4    Wels, W.S.5    Reiter, Y.6
  • 62
    • 84859068537 scopus 로고    scopus 로고
    • T cell-receptor-like antibodies - Generation, function and applications
    • Dahan R and Reiter Y: T cell-receptor-like antibodies - generation, function and applications. Expert Rev Mol Med 14:e6, 2012.
    • (2012) Expert Rev Mol Med , vol.14 , pp. e6
    • Dahan, R.1    Reiter, Y.2
  • 64
    • 80855134483 scopus 로고    scopus 로고
    • TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells
    • Weidanz JA, Hawkins O, Verma B and Hildebrand WH: TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol 30:328-340, 2011.
    • (2011) Int Rev Immunol , vol.30 , pp. 328-340
    • Weidanz, J.A.1    Hawkins, O.2    Verma, B.3    Hildebrand, W.H.4
  • 65
    • 0032948397 scopus 로고    scopus 로고
    • Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: Novel reagents for basic and clinical investigations and immunotherapy
    • Engberg J, Krogsgaard M and Fugger L: Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy. Immunotechnology 4:273-278, 1999.
    • (1999) Immunotechnology , vol.4 , pp. 273-278
    • Engberg, J.1    Krogsgaard, M.2    Fugger, L.3
  • 66
    • 0030935662 scopus 로고    scopus 로고
    • Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity
    • Reiter Y, Di Carlo A, Fugger L, Engberg J and Pastan I: Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity. Proc Natl Acad Sci USA 94:4631-4636, 1997.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 4631-4636
    • Reiter, Y.1    Di Carlo, A.2    Fugger, L.3    Engberg, J.4    Pastan, I.5
  • 67
    • 0030752446 scopus 로고    scopus 로고
    • Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
    • de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ and van Muijen GN: Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223-3229, 1997.
    • (1997) Cancer Res , vol.57 , pp. 3223-3229
    • De Vries, T.J.1    Fourkour, A.2    Wobbes, T.3    Verkroost, G.4    Ruiter, D.J.5    Van Muijen, G.N.6
  • 69
    • 0028302028 scopus 로고
    • Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
    • Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E and Rosenberg SA: Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347-352, 1994.
    • (1994) J Exp Med , vol.180 , pp. 347-352
    • Kawakami, Y.1    Eliyahu, S.2    Sakaguchi, K.3    Robbins, P.F.4    Rivoltini, L.5    Yannelli, J.R.6    Appella, E.7    Rosenberg, S.A.8
  • 72
    • 84890281763 scopus 로고    scopus 로고
    • Companion biomarkers: Paving the pathway to personalized treatment for cancer
    • Duffy MJ and Crown J: Companion biomarkers: paving the pathway to personalized treatment for cancer. Clin Chem 59:1447-1456, 2013.
    • (2013) Clin Chem , vol.59 , pp. 1447-1456
    • Duffy, M.J.1    Crown, J.2
  • 75
    • 0022406444 scopus 로고
    • Amplification of a novel v-erbB-related gene in a human mammary carcinoma
    • King CR, Kraus MH and Aaronson SA: Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229:974-976, 1985.
    • (1985) Science , vol.229 , pp. 974-976
    • King, C.R.1    Kraus, M.H.2    Aaronson, S.A.3
  • 76
    • 80755188010 scopus 로고    scopus 로고
    • Expanding the targets available to therapeutic antibodies via novel disease-specific markers
    • Weidanz JA and Hildebrand WH: Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol 30:312-327, 2011.
    • (2011) Int Rev Immunol , vol.30 , pp. 312-327
    • Weidanz, J.A.1    Hildebrand, W.H.2
  • 78
    • 0034535585 scopus 로고    scopus 로고
    • Recombinant human single-chain MHC-peptide complexes made from E coli by in vitro refolding: Functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens
    • Denkberg G, Cohen CJ, Segal D, Kirkin AF and Reiter Y: Recombinant human single-chain MHC-peptide complexes made from E. coli by in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens. Eur J Immunol 30:3522-3532, 2000.
    • (2000) Eur J Immunol , vol.30 , pp. 3522-3532
    • Denkberg, G.1    Cohen, C.J.2    Segal, D.3    Kirkin, A.F.4    Reiter, Y.5
  • 79
    • 0026529908 scopus 로고
    • HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides
    • Garboczi DN, Hung DT and Wiley DC: HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89:3429-3433, 1992.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 3429-3433
    • Garboczi, D.N.1    Hung, D.T.2    Wiley, D.C.3
  • 81
    • 27144431943 scopus 로고    scopus 로고
    • Selecting and screening recombinant antibody libraries
    • Hoogenboom HR: Selecting and screening recombinant antibody libraries. Nat Biotechnol 23:1105-1116, 2005.
    • (2005) Nat Biotechnol , vol.23 , pp. 1105-1116
    • Hoogenboom, H.R.1
  • 84
    • 0034678450 scopus 로고    scopus 로고
    • Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex
    • Krogsgaard M, Wucherpfennig KW, Cannella B, Hansen BE, Svejgaard A, Pyrdol J, Ditzel H, Raine C, Engberg J and Fugger L: Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J Exp Med 191:1395-1412, 2000.
    • (2000) J Exp Med , vol.191 , pp. 1395-1412
    • Krogsgaard, M.1    Wucherpfennig, K.W.2    Cannella, B.3    Hansen, B.E.4    Svejgaard, A.5    Pyrdol, J.6    Ditzel, H.7    Raine, C.8    Engberg, J.9    Fugger, L.10
  • 85
    • 0041428152 scopus 로고    scopus 로고
    • Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen
    • Denkberg G, Lev A, Eisenbach L, Benhar I and Reiter Y: Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen. J Immunol 171:2197-2207, 2003.
    • (2003) J Immunol , vol.171 , pp. 2197-2207
    • Denkberg, G.1    Lev, A.2    Eisenbach, L.3    Benhar, I.4    Reiter, Y.5
  • 86
    • 0030745938 scopus 로고    scopus 로고
    • Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody
    • Dadaglio G, Nelson CA, Deck MB, Petzold SJ and Unanue ER: Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6:727-738, 1997.
    • (1997) Immunity , vol.6 , pp. 727-738
    • Dadaglio, G.1    Nelson, C.A.2    Deck, M.B.3    Petzold, S.J.4    Unanue, E.R.5
  • 87
    • 0030849769 scopus 로고    scopus 로고
    • Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
    • Porgador A, Yewdell JW, Deng Y, Bennink JR and Germain RN: Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715-726, 1997.
    • (1997) Immunity , vol.6 , pp. 715-726
    • Porgador, A.1    Yewdell, J.W.2    Deng, Y.3    Bennink, J.R.4    Germain, R.N.5
  • 91
    • 0037108683 scopus 로고    scopus 로고
    • Direct detection and quantitation of a distinct T cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells
    • Cohen CJ, Hoffmann N, Farago M, Hoogenboom HR, Eisenbach L and Reiter Y: Direct detection and quantitation of a distinct T cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Res 62:5835-5844, 2002.
    • (2002) Cancer Res , vol.62 , pp. 5835-5844
    • Cohen, C.J.1    Hoffmann, N.2    Farago, M.3    Hoogenboom, H.R.4    Eisenbach, L.5    Reiter, Y.6
  • 92
    • 0012054787 scopus 로고    scopus 로고
    • Generation of recombinant immunotoxins for specific targeting of tumorrelated peptides presented by MHC molecules
    • Cohen CJ, Denkberg G, Segal D and Reiter Y: Generation of recombinant immunotoxins for specific targeting of tumorrelated peptides presented by MHC molecules. Methods Mol Biol 207:269-282, 2003.
    • (2003) Methods Mol Biol , vol.207 , pp. 269-282
    • Cohen, C.J.1    Denkberg, G.2    Segal, D.3    Reiter, Y.4
  • 93
    • 51049104493 scopus 로고    scopus 로고
    • Antitumor activity of immunotoxins with T cell receptor-like specificity against human melanoma xenografts
    • Klechevsky E, Gallegos M, Denkberg G, Palucka K, Banchereau J, Cohen C and Reiter Y: Antitumor activity of immunotoxins with T cell receptor-like specificity against human melanoma xenografts. Cancer Res 68:6360-6367, 2008.
    • (2008) Cancer Res , vol.68 , pp. 6360-6367
    • Klechevsky, E.1    Gallegos, M.2    Denkberg, G.3    Palucka, K.4    Banchereau, J.5    Cohen, C.6    Reiter, Y.7
  • 94
    • 49649129991 scopus 로고    scopus 로고
    • Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies
    • Epel M, Carmi I, Soueid-Baumgarten S, Oh SK, Bera T, Pastan I, Berzofsky J and Reiter Y: Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. Eur J Immunol 38:1706-1720, 2008.
    • (2008) Eur J Immunol , vol.38 , pp. 1706-1720
    • Epel, M.1    Carmi, I.2    Soueid-Baumgarten, S.3    Oh, S.K.4    Bera, T.5    Pastan, I.6    Berzofsky, J.7    Reiter, Y.8
  • 95
    • 77949895698 scopus 로고    scopus 로고
    • TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models
    • Verma B, Neethling FA, Caseltine S, Fabrizio G, Largo S, Duty JA, Tabaczewski P and Weidanz JA: TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models. J Immunol 184:2156-2165, 2010.
    • (2010) J Immunol , vol.184 , pp. 2156-2165
    • Verma, B.1    Neethling, F.A.2    Caseltine, S.3    Fabrizio, G.4    Largo, S.5    Duty, J.A.6    Tabaczewski, P.7    Weidanz, J.A.8
  • 98
    • 84873587154 scopus 로고    scopus 로고
    • Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes
    • Jain R, Rawat A, Verma B, Markiewski MM and Weidanz JA: Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes. J Natl Cancer Inst 105:202-218, 2013.
    • (2013) J Natl Cancer Inst , vol.105 , pp. 202-218
    • Jain, R.1    Rawat, A.2    Verma, B.3    Markiewski, M.M.4    Weidanz, J.A.5
  • 104
    • 84890179288 scopus 로고    scopus 로고
    • Of CARs and TRUCKs: Chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
    • Chmielewski M, Hombach AA and Abken H: Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Immunol Rev 257:83-90, 2014.
    • (2014) Immunol Rev , vol.257 , pp. 83-90
    • Chmielewski, M.1    Hombach, A.A.2    Abken, H.3
  • 105
    • 84858759305 scopus 로고    scopus 로고
    • Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
    • Pegram HJ, Lee JC, Hayman EG, Imperato GH, Tedder TF, Sadelain M and Brentjens RJ: Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 119:4133-4141, 2012.
    • (2012) Blood , vol.119 , pp. 4133-4141
    • Pegram, H.J.1    Lee, J.C.2    Hayman, E.G.3    Imperato, G.H.4    Tedder, T.F.5    Sadelain, M.6    Brentjens, R.J.7
  • 108
    • 0038516286 scopus 로고    scopus 로고
    • The choices of a natural killer
    • Trinchieri G: The choices of a natural killer. Nat Immunol 4:509-510, 2003.
    • (2003) Nat Immunol , vol.4 , pp. 509-510
    • Trinchieri, G.1
  • 112
    • 84877575144 scopus 로고    scopus 로고
    • Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
    • Kochenderfer JN and Rosenberg SA: Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol 10:267-276, 2013.
    • (2013) Nat Rev Clin Oncol , vol.10 , pp. 267-276
    • Kochenderfer, J.N.1    Rosenberg, S.A.2
  • 114
    • 80054680991 scopus 로고    scopus 로고
    • Treating cancer with genetically engineered T cells
    • Park TS, Rosenberg SA and Morgan RA: Treating cancer with genetically engineered T cells. Trends Biotechnol 29:550-557, 2011.
    • (2011) Trends Biotechnol , vol.29 , pp. 550-557
    • Park, T.S.1    Rosenberg, S.A.2    Morgan, R.A.3
  • 115
    • 84868573518 scopus 로고    scopus 로고
    • Genetic modification of human T lymphocytes for the treatment of hematologic malignancies
    • Hoyos V, Savoldo B and Dotti G: Genetic modification of human T lymphocytes for the treatment of hematologic malignancies. Haematologica 97:1622-1631, 2012.
    • (2012) Haematologica , vol.97 , pp. 1622-1631
    • Hoyos, V.1    Savoldo, B.2    Dotti, G.3
  • 118
    • 1642348370 scopus 로고    scopus 로고
    • Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma
    • Lin P, Owens R, Tricot G and Wilson CS: Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 121:482-488, 2004.
    • (2004) Am J Clin Pathol , vol.121 , pp. 482-488
    • Lin, P.1    Owens, R.2    Tricot, G.3    Wilson, C.S.4
  • 119
    • 78649899281 scopus 로고    scopus 로고
    • Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: Improvement of their immune activity by expression of CD33-specific chimeric receptors
    • Marin V, Pizzitola I, Agostoni V, Attianese GM, Finney H, Lawson A, Pule M, Rousseau R, Biondi A and Biagi E: Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors. Haematologica 95:2144-2152, 2010.
    • (2010) Haematologica , vol.95 , pp. 2144-2152
    • Marin, V.1    Pizzitola, I.2    Agostoni, V.3    Attianese, G.M.4    Finney, H.5    Lawson, A.6    Pule, M.7    Rousseau, R.8    Biondi, A.9    Biagi, E.10
  • 125
    • 84892365940 scopus 로고    scopus 로고
    • Checkpoint blocking antibodies in cancer immunotherapy
    • Kyi C and Postow MA: Checkpoint blocking antibodies in cancer immunotherapy. FEBS Lett 588:368-376, 2014.
    • (2014) FEBS Lett , vol.588 , pp. 368-376
    • Kyi, C.1    Postow, M.A.2
  • 126
    • 84879599112 scopus 로고    scopus 로고
    • At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
    • Callahan MK and Wolchok JD: At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol 94:41-53, 2013.
    • (2013) J Leukoc Biol , vol.94 , pp. 41-53
    • Callahan, M.K.1    Wolchok, J.D.2
  • 127
    • 84877022722 scopus 로고    scopus 로고
    • Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
    • Quezada SA and Peggs KS: Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer. Br J Cancer 108:1560-1565, 2013.
    • (2013) Br J Cancer , vol.108 , pp. 1560-1565
    • Quezada, S.A.1    Peggs, K.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.